The International Society of Antimicrobial Chemotherapy (ISAC) announced it has selected Robin Patel to receive the 2022 Hamao Umezawa Memorial Award (HUMA). Dr. Patel serves as ARLG’s Laboratory Center Director and is the Director of the Infectious Diseases Research Laboratory at the Mayo Clinic.
Dr. Patel’s work focuses on developing improved diagnostic approaches to combat antibacterial resistance, researching the mechanisms of biofilm formation, and designing and conducting studies for new antibacterial treatment options. Her numerous career highlights include serving as president of the American Society for Microbiology, a council member for the National Institutes of Allergy and Infectious Diseases, and an associate editor for the Journal of Clinical Microbiology. She has published more than 500 peer-reviewed publications.
HUMA, which is ISAC’s highest award, recognizes outstanding contributions in the field of antimicrobial chemotherapy by a researcher, scientist, or clinician. Dr. Patel will receive her award medal, certificate, and 10,000 Swiss Francs during the 32nd International Congress of Antimicrobial Chemotherapy (ICC 2022) scheduled for November 70 – 30 in Perth, Australia. She will deliver the HUMA plenary lecture on “Microbial Theranostics – A Resistance Combatting Strategy”.